Skip to main content

TG Therapeutics, Inc.

TGTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001001316

In the last 90 days, TG Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 431 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; no superinvestor holds it.

Politicians who traded TGTX

Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.

Trades
1
Filings
1
Politicians
1
Buys / sells
0 / 1
Estimated volume
$8.00K
Sum of range midpoints
Politicians who traded TGTX
PoliticianTradesBuys / sellsEst. volumeLast tradedLast filed
Chris Jacobs House · NY
10 / 1$8.00KSep 8, 2020Nov 6, 2020

Trades

Reported trades in TG Therapeutics, Inc., newest filings first.

Politician trades
PoliticianAssetTypeOwnerTradedFiledDelayAmountSource
Chris Jacobs House · NY
TGTXTG Therapeutics, Inc.Sell (partial)SelfSep 8, 2020Nov 6, 202059 daysLate$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.